Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vytorin Fails To Show ENHANCEd Benefit Over Simvastatin In Plaque Reduction

This article was originally published in The Pink Sheet Daily

Executive Summary

Merck/Schering-Plough felt pressure to release findings earlier than its scheduled presentation at March American College of Cardiology meeting, Schering-Plough tells “The Pink Sheet” DAILY.

You may also be interested in...



HCV Among Merck’s Gains With Schering, But Future Moves Still Murky

As Merck and Schering-Plough await a potential monkey wrench from Johnson & Johnson for their merger, observers are sorting through each company's partnerships for would-be redundancies

HCV Among Merck’s Gains With Schering, But Future Moves Still Murky

As Merck and Schering-Plough await a potential monkey wrench from Johnson & Johnson for their merger, observers are sorting through each company's partnerships for would-be redundancies

Vytorin Re-Endorsed By FDA Despite Lack Of Impact On Carotid Artery Thickness

Agency offers three possible explanations for why a reduction in LDL failed to translate into a drop in cIMT.

Related Content

Topics

UsernamePublicRestriction

Register

PS066724

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel